Featured Research

from universities, journals, and other organizations

Elbow Ligament Reconstruction Appears Not To Effect Future Professional Advancement In Baseball

Date:
February 28, 2009
Source:
American Orthopaedic Society for Sports Medicine
Summary:
Elbow ulnar collateral ligament reconstruction prior to selection in the Major League Baseball draft does not increase the risk of future injury or affect the rate of professional advancement, according to a new study.

New research to be presented at the 2009 American Orthopaedic Society of Sports Medicine Specialty Day in Las Vegas suggests that elbow ulnar collateral ligament (UCL) reconstruction prior to selection in the Major League Baseball (MLB) draft does not increase the risk of future injury or affect the rate of professional advancement.

Related Articles


“Our study showed no statistical difference between athletes who had undergone UCL reconstruction prior to the draft and a matched control group in terms of advancement in professional baseball” said Gregory F. Carolan, MD, lead author and Director of Orthopaedic Sports Medicine at St. Luke’s Hospital in Bethlehem, PA. Dr. Carolan is a former fellow at the San Diego Arthroscopy & Sports Medicine Program and The Scripps Clinic, San Diego, CA where the research was conducted in conjunction with the San Diego Padres Baseball Club.Other doctors involved in the project included Jan Fronek, MD, Christopher Geary, MD, James Koziol, MD, Daniel Keefe, MD and Heinz Hoenecke, MD.

The researchers reviewed the medical records of all players selected during the five MLB drafts held from 1999 through 2003 and identified 30 players (all but 3 were pitchers) who had undergone UCL reconstruction (RUCL) prior to entering the draft. The data analyzed included the highest level of professional advancement, the number of times players were placed on the disabled list (DL), the type of injury responsible for placement on the DL and game statistics for those players that advanced to the Major Leagues. There was no statistically significant difference in any of these areas between the RUCL group and the control group.

“Our data shows that UCL reconstruction prior to selection in the MLB draft does not appear to increase the chances of a future injury to the throwing arm or impact a player’s professional prospects when compared to a matched control group. Our analysis is sufficiently powered to detect large differences between the two groups; however our ongoing research will continue to add confidence that we are not missing more subtle differences. As more athletes undergo the procedure and enter the MLB draft, we hope to be able to accomplish this goal. With the increase in UCL reconstructions being performed, it is heartening to see that the procedure can be successful in allowing future professional athletes to the reach the highest level of competition on par with their peers,” said Carolan.


Story Source:

The above story is based on materials provided by American Orthopaedic Society for Sports Medicine. Note: Materials may be edited for content and length.


Cite This Page:

American Orthopaedic Society for Sports Medicine. "Elbow Ligament Reconstruction Appears Not To Effect Future Professional Advancement In Baseball." ScienceDaily. ScienceDaily, 28 February 2009. <www.sciencedaily.com/releases/2009/02/090228075730.htm>.
American Orthopaedic Society for Sports Medicine. (2009, February 28). Elbow Ligament Reconstruction Appears Not To Effect Future Professional Advancement In Baseball. ScienceDaily. Retrieved November 26, 2014 from www.sciencedaily.com/releases/2009/02/090228075730.htm
American Orthopaedic Society for Sports Medicine. "Elbow Ligament Reconstruction Appears Not To Effect Future Professional Advancement In Baseball." ScienceDaily. www.sciencedaily.com/releases/2009/02/090228075730.htm (accessed November 26, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Wednesday, November 26, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Pet Dogs to Be Used in Anti-Ageing Trial

Pet Dogs to Be Used in Anti-Ageing Trial

Reuters - Innovations Video Online (Nov. 26, 2014) Researchers in the United States are preparing to discover whether a drug commonly used in human organ transplants can extend the lifespan and health quality of pet dogs. Video provided by Reuters
Powered by NewsLook.com
From Popcorn To Vending Snacks: FDA Ups Calorie Count Rules

From Popcorn To Vending Snacks: FDA Ups Calorie Count Rules

Newsy (Nov. 25, 2014) The US FDA is announcing new calorie rules on Tuesday that will require everywhere from theaters to vending machines to include calorie counts. Video provided by Newsy
Powered by NewsLook.com
Daily Serving Of Yogurt Could Reduce Risk Of Type 2 Diabetes

Daily Serving Of Yogurt Could Reduce Risk Of Type 2 Diabetes

Newsy (Nov. 25, 2014) Need another reason to eat yogurt every day? Researchers now say it could reduce a person's risk of developing type 2 diabetes. Video provided by Newsy
Powered by NewsLook.com
Madagascar Working to Contain Plague Outbreak

Madagascar Working to Contain Plague Outbreak

AFP (Nov. 24, 2014) Madagascar said Monday it is trying to contain an outbreak of plague -- similar to the Black Death that swept Medieval Europe -- that has killed 40 people and is spreading to the capital Antananarivo. Duration: 00:42 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins